3 citations
,
January 2010 in “PubMed” This review discusses various conventional and experimental treatments for keloids and hypertrophic scars, noting the unknown pathogenetic mechanisms and need for further research into safety and efficacy, and reports no new clinical results.
February 2025 in “Journal of Neonatal Surgery” This study reports that non-surgical treatments like triamcinolone acetonide and Botulinum toxin Type A reduced keloid volume by up to 80% in children, with combination therapies being safer and having fewer side effects.
3 citations
,
August 2019 in “JAAD Case Reports” This case study reports a unique instance of temporary alopecia occurring after intralesional 5-fluorouracil treatment for keloids, marking the first such report associated with this localized chemotherapy approach.
July 2025 in “Journal of the Pakistan Medical Association” In this study, intralesional triamcinolone acetonide combined with 5-fluorouracil was more effective for treating keloids, showing a good to excellent response in 95% of cases and fewer side effects, compared to triamcinolone acetonide alone, which achieved a 70% response rate.
January 2025 in “Dermatologic Therapy” This retrospective study reported significant improvements in keloid scars among 60 patients treated with punch excision and superficial X-ray, with lower Vancouver Scar Scale and Patient and Observer Scar Assessment Scale scores a year post-treatment and no severe adverse reactions observed.
